This session will help explore the latest developments in targeted therapies for non-small cell lung cancer (NSCLC), helping cancer nurses strengthen their knowledge of EGFR mutations, emerging treatments, and nursing management in practice.
Please accept {{cookieConsents}} cookies to view this content